Skip to main content

People in the News: Mar 2, 2010


Joel McComb is leaving his post as senior vice president and general manager of Illumina's Life Sciences business to become chief operating officer at Synthetic Genomics. McComb departed Illumina and took on the new position at SGI on March 1.

Before his time at Illumina, McComb was at General Electric, where he was president of Healthcare Life Sciences-Discovery Systems, and he served as president of GE Healthcare, Interventional Medicine. He also previously served as president and CEO of Innovadyne Technologies, a liquid-handling technology firm.

McComb's departure agreement from Illumina entitles him to a severance payment of nearly $260,000.

Ulf Jönsson has joined PharmaDiagnostics as non-executive director, the firm said this week.

Jönsson previously served as CEO of Cellectricon. He also was a co-founder and CEO of Biacore, now part of GE Healthcare.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.